# Exenatide for Myocardial Protection During Reperfusion Study

> **NCT01938235** · PHASE2 · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 198 (estimated)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01938235
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2017-07
- **Final completion:** 2018-01
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2016-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01938235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01938235, "Exenatide for Myocardial Protection During Reperfusion Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01938235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*